is there a preference for type of car t-cell treatment? - blood cancer onctalk
Published 1 year ago • 15 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
4:11
treatment options for newly diagnosed aml: venetoclax and midostaurin - blood cancer onctalk
-
1:59
future directions for treatment of acute myeloid leukemia - blood cancer onctalk
-
3:40
should cellular therapies be moved to first line treatment? - blood cancer onctalk
-
1:31
are there any ongoing trials for acute leukemia in adults? - blood cancer onctalk
-
2:44
the future of multiple myeloma treatment - blood cancer onctalk
-
2:28:27
vod 2023 blood cancer onctalk
-
3:00
treatment for geriatric patients with aggressive lymphomas - blood cancer onctalk
-
2:16
how do treatment side effects differ in the geriatric population? - blood cancer onctalk
-
2:35
how can geriatric patients with lymphoma support their care? - blood cancer onctalk
-
12:31
tailoring chemotherapy for geriatric patients with advanced lymphoma - blood cancer onctalk
-
1:52
what are next steps for a patient with two transplants and a relapse? - blood cancer onctalk
-
2:20:58
blood cancer onctalk february 2023 on demand
-
3:29
are there clinically significant distinctions between pd-1 and pd-l1?
-
3:46
immunotherapy as first-line treatment
-
6:10
case based panel discussion - what is the recommended treatment for common egfr mutations
-
2:00
choosing first line therapy in egfr mutations